Measurements and Main Results: Of 640 study patients, 116 (18%) had fluoroquinolone exposure in the 12 months before diagnosis, and 16 (2.5%; 95% confidence interval [CI], 1.4–4.0%) M. tuberculosis isolates were fluoroquinolone resistant. Among the 54 patients with more ...